The International Linked Clinical Trials Committee
The drug selection process in our International Linked Clinical Trials (iLCT) programme is governed and evaluated by a committee of world leading scientists, physicians and advocates, all experts in their field of Parkinson’s research.
The iLCT Committee
Note: Very sadly, iLCT committee member, Professor M. Flint Beal, died in June 2021. Flint was former chair of the Department of Neurology and Neuroscience at Weill Cornell Medicine, and neurologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center and the University Professor of Neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine. He was an internationally recognized leader in neurology and neurodegenerative disorders and one of the greatest clinician-scientists of his generation.
